Table 2: Baseline laboratory results of responders and non-responders.
Total Mean (SD) |
Responders Mean (SD) |
Non-responders Mean (SD) |
P-value |
|
Age |
50.0 (10.0) |
50.0 (9.6) |
50.3 (8.0) |
0.749 |
BMI |
29.2 (5.3) |
29.2 (5.3) |
29.1 (4.8) |
0.341 |
ALT |
57.2 (38.3) |
57.1 (38.1) |
60.6 (42.6) |
0.558 |
AST |
61.9 (40.4) |
61.7 (40.3) |
67.3 (41.4) |
0.211 |
AFP |
9.7 (25.1) |
9.5 (25.2) |
14.3 (20.4) |
<0.001 |
Albumin (g/dL) |
4.0 (0.5) |
4.0 (0.5) |
3.8 (0.5) |
0.018 |
Total BILIRUBIN (mg/dL) |
0.9 (0.5) |
0.9 (0.5) |
1.0 (0.4) |
0.082 |
HbA1c*(%) |
6.4 (1.1) |
6.4 (1.1) |
5.6 (0.4) |
0.301 |
WBC × 103/mm3 |
6.1 (2.1) |
6.1 (2.1) |
5.6 (1.9) |
0.018 |
Hemoglobin (gm/L) |
13.5 (1.7) |
13.5 (1.7) |
13.4 (1.7) |
0.533 |
Platelets × 103/mm3 |
169.5 (70.5) |
170.1 (70.6) |
153.7 (65.8) |
0.015 |
Prothrombin concentration (%) |
85.5 (11.4) |
85.5 (11.4) |
85.2 (10.7) |
0.027 |
INR |
1.1 (0.2) |
1.1 (0.2) |
1.1 (0.1) |
0.185 |
Creatinine (mg/dL) |
0.9 (0.5) |
0.9 (0.5) |
0.9 (0.6) |
0.941 |
Liver Stiffness measurements |
15.7 (10.6) |
15.7 (10.6) |
17.8 (9.5) |
0.492 |
Fib4 Calculation |
3.7 (10.9) |
3.7 (11.0) |
3.5 (2.5) |
0.849 |
BMI: Body Mass Index; ALT: Alanine Transaminases; AST: Aspartate Transaminases; AFP: Alpha-Fetoprotein, HbA1C: Glycosylated Hemoglobin; INR: International Normalized Ratio